Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple fibre supplement tame ulcerative colitis Flare-Ups?

NCT ID NCT06515210

First seen Jun 12, 2026 · Last updated Jun 19, 2026 · Updated 1 time

Summary

This study is testing whether two types of fibre supplements—acacia gum and microcrystalline cellulose—can lower gut inflammation in people with ulcerative colitis. Sixty-nine participants will add one of the fibres or a placebo to their usual diet for six weeks. Researchers will measure changes in a stool marker of inflammation (calprotectin) and track symptoms. The goal is to see if personalized fibre supplements could become a simple, complementary strategy for managing the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Alberta Hospital

    RECRUITING

    Edmonton, Alberta, T6G 2X8, Canada

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Acacia gum and microcrystalline cellulose (dietary fibre supplements)

What this could lead to

If it works, this could point toward a simple, personalized dietary supplement strategy to help manage ulcerative colitis inflammation.

What could go wrong

This is a small, early-phase trial (69 people) testing dietary supplements, not a drug. The effect on inflammation may be modest or no better than placebo, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

Inflammatory Bowel Diseases ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.